Article information
Full text is only aviable in PDF
REFERENCES
[1]
KF Bonese, BH Wainer, FW Fitch, RM Rothberg, CR Shuster.
Changes in heroin self administration by rhesus monkey after morphine immunization.
Nature, 252 (1974), pp. 708-710
[2]
A Killian, K Bonese, RM Rothberg, BH Wainer, CR Schuster.
Effects of passive immunization against morphine on heroin administration.
Pharmacol Biochem Behav., 9 (1978), pp. 347-352
[3]
JI Granda Orive, S Solano Reina, CA Jiménez Ruiz, T Gutiérrez Jiménez, JM Martínez Albiach.
La vacuna antinicotina.
Otoneumoalergia Práctica, 12 (2003), pp. 20-24
[4]
Granda Orive JI. El tabaquismo como enfermedad adictiva crónica. In: Jiménez Ruiz CA, Fagerström K, editors. Tratado de tabaquismo. Grupo Aula Médica. In press. 2004.
[5]
MRA Carrera, JA Ashley, LH Parsons, P Wirsching, GF Koob, KD Janda.
Suppression of psychoactive effects of cocaine by active immunization.
Nature, 378 (1995), pp. 727-730
[6]
BS Fox, KM Kantak, MA Edwards, KM Black, BK Böllinger, AJ Botka, et al.
Efficacy of a therapeutic cocaine vaccine in rodent models.
Nature Medicine, 2 (1996), pp. 1129-1132
[7]
DA Keyler, Y Hieda, JS Peter, PR Pentel.
Altered disposition of repeated nicotine doses in rats immunized against nicotine.
Nicotine Tob Res., 1 (1999), pp. 241-249
[8]
Y Hieda, DE Keyler, JT Vandervoort, JK Kane, CA Ross, DE Raphael, et al.
Active immunization alters the plasma nicotine concentration in rats.
J Pharmacol Experimental Ther., 283 (1997), pp. 1076-1081
[9]
Y Hieda, DE Keyler, S Ennifar, A Fattom, PR Pentel.
Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain.
Int J Inmunopharmacol., 22 (2000), pp. 809-819
[10]
PR Pentel, DH Malin, S Ennifar, Y Hieda, DE Keyler, JR Lake, et al.
A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats.
Pharmacol Biochem Behv., 65 (2000), pp. 191-198
[11]
N Lindblom, SHL de Villiers, G Kalayanov, S Gordon, AM Johansson, TH Svensson.
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats.
Respiration, 69 (2002), pp. 254-260
[12]
SHL de Villiers, N Lindhom, G Kalayanov, S Gordon, A Malmerfelt, AM Johansson, et al.
Active immunization against nicotine-induced dopamine release in the rats nucleus accumbens shell.
Respiration, 69 (2002), pp. 247-253
[13]
DH Malin, JR Lake, A Lin, M Saldana, L Balch, ML Irvin, et al.
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
Pharmacol Biochem Behav., 68 (2001), pp. 87-92
[14]
TA-NIC nicotine vaccine.
[15]
Clair Roberts JS, Dobson J, Wood D, Settles M. Safety and immunogenicity of nicotine conjugate vaccine. Proceedings of Annual Meeting of the College on Problems of Drug Dependence CPDD; 2002, June; Quebec City.
[16]
Clair Roberts JS, Akers CVR, Vanhinsbergh L, McKenna KA, Wood DM, Jack L, et al. Longitudinal safety and immunogenicity data of TA-NIC, a novel nicotine vaccine. Proceedings of Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT); 2003, November; Padua.
[17]
Lindmayer K, Horwith G, Fattom A, Naso R, Fuller S, Muenz L, et al. Results of a phase 1, double blinded, controlled safety and immunogenicity trial of NICVAXTM, a conjugated nicotine vaccine. Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT); 2002, O ctober; Santander.
[18]
Lindmayer K, Horwith G, Fattom A, Naso R, Fuller S, Muenz L, et al. Results of a phase 1, double blinded, controlled safety and immunogenicity trial of NICVAXTM, a conjugated nicotine vaccine. Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT); 2003, November; Padua.
[19]
CJ Bunce, PT Loudon, C Akers, J Dobson, DM Wood.
Development of vaccines to help treat drug dependence.
Curr Opin Mol Ther., 5 (2003), pp. 58-63
[20]
SD Satoskar, DE Keyler, MG le Sage, DE Raphael, C Ross, PR Pentel.
Tissue dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats.
Int Immunopharmacol., 3 (2003), pp. 957-970
[21]
P Pentel, D Malin.
A vaccine for nicotine dependence: targeting the drug rather than the brain.
Respiration, 69 (2002), pp. 193-197
[22]
EH Cerny, R Lévy, J Mauel, M Mpandi, M Mutter, C Henzelin-Nkubana, et al.
Preclinical development of a vaccine against smoking.
Onkologie, 25 (2002), pp. 406-411
[23]
SD Sanderson, SR Cheruku, MP Padmanilayam, JL Vennerstrom, GM Thiele, MI Palmatier, et al.
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant.
Int Immunopharmacol., 3 (2003), pp. 137-146
[24]
MRA Carrera, JA Ashley, TZ Hoffman, S Isomura, P Wirsching, GF Koob, et al.
Investigation using immunization to attenuate the psychoactive effects of nicotine.
Bioorg Med Chem., 12 (2004), pp. 563-570
[25]
EM Sellers, HL Kaplan, RF Tyndale.
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Clin Pharmacol Ther., 68 (2000), pp. 35-43
[26]
MM Meijler, M Matsushita, LJ Altobell, P Wirsching, KD Janda.
A new strategy for improved nicotine vaccines using conformationally constrained haptens.
J Am Chem Soc., 125 (2003), pp. 7164-7165
[27]
Respiratory Reviews.com. New approaches to smoking cessation show promise.
[28]
W Hall.
The prospects for immunotherapy in smoking cessation.
Lancet, 360 (2002), pp. 1089-1091
[29]
FJ Vocci, CN Chiang.
Vaccines against nicotine: how effective are they likely to be in preventing smoking?.
CNS Drugs, 15 (2001), pp. 505-514
[30]
DE Keyler, D Shoeman, MG Lessge, AD Calvin, PR Pentel.
Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats.
J Pharmacol Exp Ther., 305 (2003), pp. 587-592
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
